Equities
  • Price (EUR)17.03
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-1.86%
  • Beta--
Data delayed at least 15 minutes, as of May 25 2022 07:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Medical Properties Trust, Inc. is a real estate investment trust (REIT), which is engaged in the business of investing in, owning, and leasing healthcare real estate. The Company conducts all of its operations through its subsidiary, MPT Operating Partnership, L.P. The Company acquires and develops healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases. It also makes mortgage loans to healthcare operators collateralized by their real estate assets. In addition, the Company selectively make loans to certain of its operators through its taxable REIT subsidiaries (TRS). The Company have healthcare investments in the United States, Europe, Australia, and South America. The Company’s portfolio (including real estate assets in joint ventures) consists of approximately 438 properties leased or loaned to 53 operators, of which three are under development and five were in the form of mortgage loans.

  • Revenue in USD (TTM)1.59bn
  • Net income in USD1.12bn
  • Incorporated2003
  • Employees112.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MPW:NYQ since
announced
Transaction
value
Springstone IncAnnounced15 Jun 202115 Jun 2021Announced-14.41%--
Springstone Inc-Behavioral Health Facility Portfolio(18)Deal completed15 Jun 202115 Jun 2021Deal completed-14.41%950.00m
Data delayed at least 15 minutes, as of May 25 2022 20:15 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.